Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area

Investigacion Clinica

Volumn 50, Issue 2, 2009, Pages 203-212

  Núñez Troconis, José ^a,b   Delgado, Mariela ^b   González, Julia ^b   Mindiola, Raimy ^c   Velásquez, Jesvy ^c   Conde, Betty ^d   Whitby, Denise ^d   Munroe, David J ^d  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Maracaibo Policlinic ^*  (Venezuela)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

^d SAIC FREDERICK INC   (United States)

Author keywords

Human papillomavirus; Hybrid capture 2; Prevalence; Venezuela

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENITAL TRACT INFECTION; GYNECOLOGICAL EXAMINATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; OUTPATIENT; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; TERTIARY HEALTH CARE; URBAN AREA; VENEZUELA; VIRUS INFECTION; AGE; ANAMNESIS; DNA PROBE; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; STATISTICS; URBAN POPULATION; UTERINE CERVICITIS; VAGINA SMEAR; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; DNA PROBES, HPV; EDUCATIONAL STATUS; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REPRODUCTIVE HISTORY; RISK FACTORS; URBAN POPULATION; UTERINE CERVICITIS; VAGINAL SMEARS; VENEZUELA; YOUNG ADULT;

EID: 70349562574     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide. IARC CancerBase No 5 version 2.0Lyon: IARC Press; 2004.
2. Waggoner SE. Cervical cancer. Lancet 2003; 361:2217-2225.
3. Bosch FX, de Sanjosé S. Human papillomavirus and cervical cancer: Burden and assessment of casualty. J Natl Cancer Inst Monogr 2001; 31:3-13.
4. Núñez-Troconis J. Cervical intraepithelial neoplasia: Chlamydia trachomatis and other co-factors. Invest Clin 1995; 36:101-116.
5. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006; 24(Suppl 3): S3/52- 61.
6. Snijders PJF, Steenbergen RDM, Heideman DAM, Meijer CJLM. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006:208; 152-164. (Pubitemid 43126109)
7. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews/Cancer. 2002; 2:342-350. (Pubitemid 37328947)
8. Cox JT. The development of cervical cancer and its precursors: what is the role of human papillomavirus infection? Curr Opin Obstet Gynecol 2006; 18(suppl 1): S5-S13.
9. Wright TC, Bosch FZ, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A. HPV vaccines and screening in the prevention of cervical cancer: conclusions from a 2006 workshop of international experts. Vaccine 2006; 24(Suppl 3):S3:251-261.
10. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Franceschi S, and the IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005: 366:991-998.
11. Mendoza JA, Muñoz M, Vielma S, Noguera ME, López M, Toro M. Infección cervical por el virus del papiloma humano: diagnóstico por citología y por captura de híbridos del ADN viral. Rev Obstet Ginecol Ven 2000; 60(2):103-106.
12. Scuceces M, Paneccasio A. Lesión intraepitelial cervical asociada a virus de papiloma humano. Rev Obstet Ginecol Ven 2001; 61(2):101-107.
13. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265. (Pubitemid 34293391)
14. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kupek E, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19. (Pubitemid 29406813)
15. Muñoz N, Bosch FX, de San José S, Herrero R, Castellsague X, Shah KV, Snijerds PJF, Meijer CJLM, for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527.
16. Nyári TA, Kalmár L, Deák J, Szõllõsi J, Farkas I, Kovács L. Prevalence and risk factors of human papillomavirus infection in asymptomatic women in southeastern Hungary. Eur J Obstet Gynecol 2004; 115: 99-100.
17. Ponten J, Adami HO, Bergestrom R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparén P, Trichopoulos D. Strategies for global control of cervical cancer. Int J Cancer 1995; 60:1-26.
18. Trottier H, Franco EL. The epidemiology of human papillomavirus infection. Vaccine. 2006; 24(Suppl 1): S1/4-15.
19. Herrero R, Hildesheim A, Bratte C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92(6):464-474. (Pubitemid 30182883)
20. Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC. Prevalence of high-risk human papillomavirus(HR-HPV) types 16-18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol 2004; 121:104-109. (Pubitemid 40884647)
21. Gjooen K, Olsen AO, Magnus P, Grinde B, Sauer T, Orstavik I. Prevalence of human papillomavirus in cervical scrapes as analyzed by PCR, in a population based sample of women with and without cervical dysplasia. APMIS 1996; 104(1):68-74. (Pubitemid 26083443)
22. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund S, Dehovitz J, Landesman S. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Trans Dis 1996; 23(4):333-341. (Pubitemid 26250669)
23. Ho GY, Bierman R, Beardslley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338(7):423-428. (Pubitemid 28135669)
24. Baay MFD, Sunits E, Tjalma WAA, Lardon F, Weyler J, Van Royen P, Van Marck EAE, Vermorken JB. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer 2004; 108(2):258-261. (Pubitemid 37541780)
25. Stanley M, Lowy D, Frazer I. Prophylactic HPV vaccines: Underlying mechanisms. Vaccine 2006; 24(Suppl 3):S3/106-113. (Pubitemid 44293025)
26. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.
27. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191:1796-1807. (Pubitemid 40705385)
28. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157(3): 218-226.
29. Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev 2002; 11(9):930-934. (Pubitemid 35014900)
30. Palacio-Mejias LS, Rangel-Gómez G, Hernández-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: Mortality differences between urban and rural areas in México. Salud Publica Mex 2003; 45(supp 3):S3/15-25. (Pubitemid 38029648)
31. Clifford G, Franceschi S, Díaz M, Múñoz N, Villa LL. HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24(S3):S3/ 26-34. (Pubitemid 44293021)